ELDN - Eledon Pharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

ELDN is currently covered by 2 analysts with an average price target of $20.05. This is a potential upside of $17.99 (873.3%) from yesterday's end of day stock price of $2.06.

Eledon Pharmaceuticals's activity chart (see below) currently has 4 price targets and 9 ratings on display. The stock rating distribution of ELDN is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ELDN is $3, Lowest price target is $1, average price target is $20.05.

Most recent stock forecast was given by VERNON BERNARDINO from HC WAINWRIGHT on 13-Nov-2023. First documented stock forecast 08-Feb-2021.

Best performing analysts who are covering ELDN - Eledon Pharmaceuticals:

Thomas Smith Alethia Young Vernon Bernardino

Currently out of the existing stock ratings of ELDN, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

33

1 years 10 months 28 days ago

0/2 (0%)

$22.37 (210.44%)

Buy

25

$22.35 (843.40%)

3 years 1 months 7 days ago

0/1 (0%)

$11.78 (89.11%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ELDN (Eledon Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ELDN (Eledon Pharmaceuticals) with a proven track record?

THOMAS SMITH

Which analyst has the current lower performing score on ELDN (Eledon Pharmaceuticals) with a proven track record?

VERNON BERNARDINO

Which analyst has the most public recommendations on ELDN (Eledon Pharmaceuticals)?

Thomas Smith works at LEERINK and has 3 price targets and 3 ratings on ELDN

Which analyst is the currently most bullish on ELDN (Eledon Pharmaceuticals)?

Alethia Young with highest potential upside - $22.35

Which analyst is the currently most reserved on ELDN (Eledon Pharmaceuticals)?

Thomas Smith with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?